ggwpq - The problem I have with your statement that the FDA believe's treating Trig's in the 200 to 500 class is a must has not been documented or even stated casually (meaning not legally documented) by the FDA...
If there was a health issue for that class, Amarin could go for it or may have been approved for it like the FDA approved Vascepa in the Marine class...
There is none.
The FDA allowed Marine not because it reduce's CVE's yet ONLY because reducing Very High Trig's helps reduce the risk of Pancreatis.
Without that Medical Condition we would not have an approved product.
If you can find a Health Condition that the FDA agrees is helped by the Reduction in Trig's in the 200 to 500 class, I am sure all of us on this board would like to see it.
News 
Market Data 
Discover 
